<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd">
<html id="nojs" xmlns="http://www.w3.org/1999/xhtml" xmlns:m="http://www.w3.org/1998/Math/MathML" xmlns:og="http://ogp.me/ns#" xml:lang="en-GB" lang="en-GB" xmlns:wb=“http://open.weibo.com/wb”>

<head>

   
  
      
  
                  
  
                  
  
            
  
            
            
    <title>Trials | Full text | Improving the pre-screening of eligible patients in order to increase enrollment in cancer clinical trials</title>
<link rel="shortcut icon" type="image/x-icon" href="/images/icon/10096/favicon.ico" />
<link rel="apple-touch-icon" sizes="72x72" href="/sites/10096/images/70.gif" />
<meta http-equiv="X-UA-Compatible" content="IE=7" />


                
    
		
		
		
		
<!-- <?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:cc="http://web.resource.org/cc/" xmlns="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/">
<cc:Work rdf:about="http://www.trialsjournal.com/content/16/1/15">
<cc:license rdf:resource="http://creativecommons.org/licenses/by/2.0/"/>
</cc:Work>
<cc:License rdf:about="http://creativecommons.org/licenses/by/2.0/">
<cc:permits rdf:resource="http://web.resource.org/cc/Reproduction"/>
<cc:permits rdf:resource="http://web.resource.org/cc/Distribution"/>
<cc:requires rdf:resource="http://web.resource.org/cc/Notice"/>
<cc:requires rdf:resource="http://web.resource.org/cc/Attribution"/>
<cc:permits rdf:resource="http://web.resource.org/cc/DerivativeWorks"/>
</cc:License>
<item rdf:about="http://www.trialsjournal.com/content/16/1/15">
<title>Improving the pre-screening of eligible patients in order to increase enrollment in cancer clinical trials</title>
<dc:title>Improving the pre-screening of eligible patients in order to increase enrollment in cancer clinical trials</dc:title>
<dc:creator>Campillo-Gimenez, Boris</dc:creator>
<dc:creator>Buscail, Camille</dc:creator>
<dc:creator>Zekri, Oussama</dc:creator>
<dc:creator>Laguerre, Brigitte</dc:creator>
<dc:creator>Le Prisé, Elisabeth</dc:creator>
<dc:creator>De Crevoisier, Renaud</dc:creator>
<dc:creator>Cuggia, Marc</dc:creator>
<dc:identifier>info:doi/10.1186/s13063-014-0535-7</dc:identifier>
<dc:identifier>info:pmid/25592642</dc:identifier>
<dc:source>Trials 2015, 16:15</dc:source>
<dc:date>2015-01-16</dc:date>

<prism:publicationName>Trials</prism:publicationName>
<prism:publicationDate>2015-01-16</prism:publicationDate>
<prism:volume>16</prism:volume>
<prism:number>1</prism:number>
<prism:section>Research</prism:section>
<prism:startingPage>15</prism:startingPage>
<prism:copyright>2015 Campillo-Gimenez et al.; licensee BioMed Central.</prism:copyright>
</item>
</rdf:RDF>
 -->
 
 
<meta name="citation_journal_title" content="Trials" />
<meta name="citation_publisher" content="BioMed Central Ltd" />


<meta name="citation_author" content="Boris Campillo-Gimenez" />
<meta name="citation_author_institution" content="Inserm U1099 - LTSI, Equipe Données Massives en Santé - Université Rennes 1, 2 rue du Professeur Léon Bernard, Rennes Cedex, 35043, France" />
<meta name="citation_author" content="Camille Buscail" />
<meta name="citation_author_institution" content="Department of Medical Information, University Hospital of Rennes, 2 rue Henri Le Guilloux, Rennes, 35000, France" />
<meta name="citation_author" content="Oussama Zekri" />
<meta name="citation_author_institution" content="Comprehensive Cancer Center Eugene Marquis (CCC), Avenue de la Bataille Flandres-Dunkerque, Rennes Cedex, 35042, France" />
<meta name="citation_author" content="Brigitte Laguerre" />
<meta name="citation_author_institution" content="Comprehensive Cancer Center Eugene Marquis (CCC), Avenue de la Bataille Flandres-Dunkerque, Rennes Cedex, 35042, France" />
<meta name="citation_author" content="Elisabeth Le Prisé" />
<meta name="citation_author_institution" content="Comprehensive Cancer Center Eugene Marquis (CCC), Avenue de la Bataille Flandres-Dunkerque, Rennes Cedex, 35042, France" />
<meta name="citation_author" content="Renaud De Crevoisier" />
<meta name="citation_author_institution" content="Comprehensive Cancer Center Eugene Marquis (CCC), Avenue de la Bataille Flandres-Dunkerque, Rennes Cedex, 35042, France" />
<meta name="citation_author" content="Marc Cuggia" />
<meta name="citation_author_institution" content="Clinical Investigation Center, University Hospital of Rennes, 2 rue du Professeur Léon Bernard, Rennes Cedex, 35043, France" />
<meta name="citation_author_institution" content="Inserm U1099 - LTSI, Equipe Données Massives en Santé - Université Rennes 1, 2 rue du Professeur Léon Bernard, Rennes Cedex, 35043, France" />


<meta name="citation_issn" content="1745-6215" />
<meta name="citation_title" content="Improving the pre-screening of eligible patients in order to increase enrollment in cancer clinical trials" />
<meta name="citation_volume" content="16" />
<meta name="citation_issue" content="1" />
<meta name="citation_date" content="2015-01-16" />
<meta name="citation_firstpage" content="15" />
<meta name="citation_doi" content="10.1186/s13063-014-0535-7" />
<meta name="citation_pdf_url" content="http://www.trialsjournal.com/content/pdf/s13063-014-0535-7.pdf" />
<meta name="citation_pmid" content="25592642" />
<link rel="alternate" type="application/pdf" title="PDF" href="http://www.trialsjournal.com/content/pdf/s13063-014-0535-7.pdf" />
<meta name="title" content="Improving the pre-screening of eligible patients in order to increase enrollment in cancer clinical trials" />
<meta name="description" content="The performance of randomized controlled trials (RCTs) is often hindered by recruitment difficulties. This study aims to explore the pre-screening phase of four prostate cancer RCTs to identify the impact of a systematic pre-selection of eligible patients for RCT recruitment." />

<meta name="dc.title" content="Improving the pre-screening of eligible patients in order to increase enrollment in cancer clinical trials" />
<meta name="dc.creator" content="Campillo-Gimenez, Boris" />
<meta name="dc.creator" content="Buscail, Camille" />
<meta name="dc.creator" content="Zekri, Oussama" />
<meta name="dc.creator" content="Laguerre, Brigitte" />
<meta name="dc.creator" content="Le Prisé, Elisabeth" />
<meta name="dc.creator" content="De Crevoisier, Renaud" />
<meta name="dc.creator" content="Cuggia, Marc" />
<meta name="dc.description" content="The performance of randomized controlled trials (RCTs) is often hindered by recruitment difficulties. This study aims to explore the pre-screening phase of four prostate cancer RCTs to identify the impact of a systematic pre-selection of eligible patients for RCT recruitment." />
<meta name="dc.source" content="Trials 2015 16:15" />
<meta name="dc.format" content="text/html" />
<meta name="dc.publisher" content="BioMed Central Ltd" />
<meta name="dc.date" content="2015-01-16" />
<meta name="dc.type" content="Research" />
<meta name="dc.identifier" content="10.1186/s13063-014-0535-7" />
<meta name="dc.identifier" content="info:pmid/25592642" />
<meta name="dc.language" content="en" />
<meta name="dc.copyright" content="2015 Campillo-Gimenez et al.; licensee BioMed Central." />
<meta name="dc.rights" content="http://creativecommons.org/licenses/by/2.0/" />
<meta name="dc.rightsAgent" content="reprints@biomedcentral.com" />

<meta name="prism.issn" content="1745-6215" />
<meta name="prism.publicationName" content="Trials" />
<meta name="prism.publicationDate" content="2015-01-16" />
<meta name="prism.volume" content="16" />
<meta name="prism.number" content="1" />
<meta name="prism.section" content="Research" />
<meta name="prism.startingPage" content="15" />
<meta name="prism.copyright" content="2015 Campillo-Gimenez et al.; licensee BioMed Central." />
<meta name="prism.rightsAgent" content="reprints@biomedcentral.com" />


        <meta name="citation_abstract_html_url" content="http://www.trialsjournal.com/content/16/1/15/abstract" />
            <meta name="citation_fulltext_html_url" content="http://www.trialsjournal.com/content/16/1/15" />
            <link rel='alternate' type='text/xml' title='XML version' href='http://www.trialsjournal.com/content/download/xml/s13063-014-0535-7.xml' />
            <link rel="image_src" href="http://www.trialsjournal.com/content/figures/s13063-014-0535-7-toc.gif" />
    
    
    
    
                    
    

<script type="text/javascript">
// must run before css
document.documentElement.id = "js";
</script>



						
   
  
      
  
                  
  
                  
  
            
  
            
            



						
        <script type="text/javascript" src="http://www.bmcimg.com/javascript/plugins/jquery-1.8.2.min-0.js"></script>

	                <link rel="stylesheet" type="text/css" href="/css/main-0.css" media="screen, print"/>
    
                <link rel="stylesheet" type="text/css" href="/css/plugins-0.css" media="screen, print"/>
    



    

			                <link rel="stylesheet" type="text/css" href="http://www.bmcimg.com/css/articles-0.css" media="screen, print"/>
    	

    

    <link rel="stylesheet" type="text/css" href="/css/themes/10096.css" media="screen, print"/>


                <link rel="stylesheet" type="text/css" href="/css/media/print-0.css" media="print"/>
    



<!--[if IE]>
                    <link rel="stylesheet" type="text/css" href="/css/hacks/ie-0.css"/>
    <![endif]-->

<!--[if IE 7]>
                    <link rel="stylesheet" type="text/css" href="/css/hacks/ie7-0.css"/>
    <![endif]-->
			
<script type="text/javascript">
    //configuration
    OAS_url = '//oas.biomedcentral.com/RealMedia/ads/';

	// control of advert's position on page [AMC]
    
    	
	
    OAS_sitepage = "trialsjournal.com/article/10.1186/s13063/014/0535/7";
    	
		OAS_listpos = 'Top,x96,Right3';
	
	
			
		OAS_query = '';
		
	

    OAS_target = '_top';
    //end of configuration
    OAS_version = 10;
    OAS_rn = '001234567890'; OAS_rns = '1234567890';
    OAS_rn = new String (Math.random()); OAS_rns = OAS_rn.substring (2, 11);
    function OAS_NORMAL(pos) {
		document.write('<a href="' + OAS_url + 'click_nx.ads/' + OAS_sitepage + '/1' + OAS_rns + '@' + OAS_listpos + '!' + pos + '?' + OAS_query + '" target="' + OAS_target + '">');
		document.write('<img src="' + OAS_url + 'adstream_nx.ads/' + OAS_sitepage + '/1' + OAS_rns + '@' + OAS_listpos + '!' + pos + '?' + OAS_query + '" border="0"/></a>');
    }
    
	function refererTerms(referer) {

	if(referer.match("q=") != null) {
		referer = referer.split("q=");
		referer = referer[1].split("&");
		referer = referer[0];
	} else {
		referer = referer;
	}

		if(referer.match("%20") != null && referer.match("%20").length >= 1) {
			referer =  referer.replace(/%20/gi,"+");
			return referer;
		} else { 
			return referer; 
		}
	}
 </script>


 <script type="text/javascript">
	// Set the version of JavaScript to 10 for a Browser 'Mozilla/3' on webTV 
    OAS_version = 11;
    if ((navigator.userAgent.indexOf('Mozilla/3') != -1) || (navigator.userAgent.indexOf('Mozilla/4.0 WebTV') != -1)) {
     OAS_version = 10; }
    if (OAS_version >= 11) {
    document.write('<scr' + 'ipt type="text/javascript" src="' + OAS_url + 'adstream_mjx.ads/' + OAS_sitepage + '/1' + OAS_rns + '@' + OAS_listpos + '?' + OAS_query + '"><\/script>'); }
</script>
	
<script type="text/javascript">
    document.write('');
	
    function OAS_AD(pos) {
        if (OAS_version >= 11)
         OAS_RICH(pos);
        else
         OAS_NORMAL(pos);
    }
 </script>
	





<script type="text/javascript">
    jsonLoaders = function(){
        var _loaders = [];
        return {
            register: function(config){
                config.prefix = config.prefix || '/webapi/1.0/blogs/';
                config.feedLength = config.feedLength || 3;

                _loaders.push(config);
            },
            list: function(){return _loaders}
        };
    }();

    function totext() {
	    document.write('<a href="javascript:returnToText();">Return to text</a>');
    }

    function retrieve_doi(){
        var metas = document.getElementsByTagName('meta');
        var i;
        for (i = 0; i < metas.length; i++)
            if (metas[i].getAttribute('name') == "citation_doi")
                break;
        var citation_doi = metas[i].getAttribute('content');
        return citation_doi;
    }

</script>





    <script src="http://tjs.sjs.sinajs.cn/open/api/js/wb.js" type="text/javascript" charset="utf-8"></script>
        <link title="Latest articles" rel="alternate" href="http://www.trialsjournal.com/latest/rss" type="application/rss+xml" exposeToHeader="true"/>
    <link title="Most viewed" rel="alternate" href="http://www.trialsjournal.com/mostviewed/rss/" type="application/rss+xml" exposeToHeader="true"/>
    <link title="Latest comments" rel="alternate" href="http://www.trialsjournal.com/latestcomments/rss" type="application/rss+xml" exposeToHeader="true"/>
    


	<script type="text/javascript">
	var _gaq = _gaq || [];
	_gaq.push(['_setAccount', 'UA-9663741-5']);
	_gaq.push(['_gat._anonymizeIp']);
	_gaq.push(['_setLocalRemoteServerMode']);
	
	/*for cross domain tracking*/
	//_gaq.push(['_setAllowLinker', true]);
    //_gaq.push(['_setDomainName', 'trialsjournal.com']); //this journal's domain
	/**/
	
		_gaq.push(['_trackPageview']); 

	(function() {
		var ga = document.createElement('script'); ga.type = 'text/javascript'; ga.async = true;
		ga.src = ('https:' == document.location.protocol ? 'https://ssl' : 'http://www') + '.google-analytics.com/ga.js';
		var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(ga, s);

		//var iframe = document.getElementById('casesdb-search-widget');
		//if(iframe !== null) {
		//	var pageTracker = _gat._getTrackerByName();
		//	iframe.src = pageTracker._getLinkerUrl('http://www.casesdatabase.com/');
		//}
	})();
	</script>

	
        </head>


<body class=" theme    ">


        



   
  
      
  
                  
  
                  
  
            
  
            
            

    

<div id="oas-campaign" style="display:none">trialsjournal.com/article/10.1186/s13063/014/0535/7</div>
<div id="oas-positions" style="display:none">Bottom,Top</div>

<div id="branding" role="banner">
                			
		<dl class="google-ad wide ">
	<dt class="hide">
					<a class="banner-ad" href="http://www.biomedcentral.com/advertisers/digital_advertising"></a>
				
			</dt>
		<dd>

		<!-- OAS AD 'Top' begin -->
		<script type="text/javascript">
		OAS_AD('Top');

		</script>
		<!-- OAS AD 'Top' end -->
		</dd>

		</dl>

		<noscript>
			<dl class="google-ad wide noscript">  
    <dt class="hide"></dt>
    
    <dd>
        <a href="//oas.biomedcentral.com/RealMedia/ads/click_nx.ads/trialsjournal.com/article/10.1186/s13063/014/0535/7/14099652834@Top?">
            <img src="//oas.biomedcentral.com/RealMedia/ads/adstream_nx.ads/trialsjournal.com/article/10.1186/s13063/014/0535/7/13827366704@Top?" alt="advert"/>
        </a>
    </dd>
			</dl>
		</noscript>
			            <div class="sup-panel-outer">
        <div class="sup-panel-inner">

            <style>
  #nojs li.greeting, #nojs li#loginLink {display:none;}
</style>


<ul id="login" class="login">

    <noscript><li><a href="/log"><img class="greeting" src="/images/log.gif"/></a></li></noscript>
    
    <li id="welcome"><span id="username"></span></li>

    <li id="loginLink"><a href=""></a></li>
    
    
</ul>

<script>

function login() {

/* cookie getter/setter */
var allCookies = {
  getItem: function (sKey) {
    if (!sKey || !this.hasItem(sKey)) { return null; }
    return unescape(document.cookie.replace(new RegExp("(?:^|.*;\\s*)" + escape(sKey).replace(/[\-\.\+\*]/g, "\\$&") + "\\s*\\=\\s*((?:[^;](?!;))*[^;]?).*"), "$1"));
  },
  setItem: function (sKey, sValue, vEnd, sPath, sDomain, bSecure) {
    if (!sKey || /^(?:expires|max\-age|path|domain|secure)$/i.test(sKey)) { return; }
    var sExpires = "";
    if (vEnd) {
      switch (vEnd.constructor) {
        case Number:
          sExpires = vEnd === Infinity ? "; expires=Tue, 19 Jan 2038 03:14:07 GMT" : "; max-age=" + vEnd;
          break;
        case String:
          sExpires = "; expires=" + vEnd;
          break;
        case Date:
          sExpires = "; expires=" + vEnd.toGMTString();
          break;
      }
    }
    document.cookie = escape(sKey) + "=" + escape(sValue) + sExpires + (sDomain ? "; domain=" + sDomain : "") + (sPath ? "; path=" + sPath : "") + (bSecure ? "; secure" : "");
  },
  removeItem: function (sKey, sPath) {
    if (!sKey || !this.hasItem(sKey)) { return; }
    document.cookie = escape(sKey) + "=; expires=Thu, 01 Jan 1970 00:00:00 GMT" + (sPath ? "; path=" + sPath : "");
  },
  hasItem: function (sKey) {
    return (new RegExp("(?:^|;\\s*)" + escape(sKey).replace(/[\-\.\+\*]/g, "\\$&") + "\\s*\\=")).test(document.cookie);
  },
  keys: /* optional method: you can safely remove it! */ function () {
    var aKeys = document.cookie.replace(/((?:^|\s*;)[^\=]+)(?=;|$)|^\s*|\s*(?:\=[^;]*)?(?:\1|$)/g, "").split(/\s*(?:\=[^;]*)?;\s*/);
    for (var nIdx = 0; nIdx < aKeys.length; nIdx++) { aKeys[nIdx] = unescape(aKeys[nIdx]); }
    return aKeys;
  }
};

// converts cookie into js object
function parseCookie(cookie) {

    cookie = cookie.split("&");
    var obj = {};

    for(var i = 0; i < cookie.length; i++) {

        var c = cookie[i].split("=");

        c[0] = c[0].replace('"','');
        
        obj[c[0]] = c[1];

    }
    return obj;
}

    var cookie = allCookies.getItem("bmccookie");

    var obj = (cookie != null) ? parseCookie(cookie) : {};
    

        var welcome = "";

        if(obj.hasOwnProperty("fname")) {

            // insert user welcome
            welcome = obj.fname.replace(/\+/g, " ") + " " + obj['lname'].replace(/\+/g," ");

            if(jQuery("#welcome").length > 0) {
              jQuery("#welcome").prepend("<strong>Welcome</strong> ");
              jQuery("#username").prepend('<strong>' + welcome + '</strong><span class="divider"></span>');
            } 

            // update link url
            jQuery("#loginLink a").text("Log off");
            jQuery("#loginLink a").attr("href", window.location.protocol + "//" + window.location.host + "/logoff");

            window.bmcloggedon = true;


        } else if(obj.hasOwnProperty("institution_name")) {

            // insert institution name
            welcome = obj["institution_name"].replace(/\+/g," ");
            
            if(jQuery("#welcome").length > 0) { 
                jQuery("#welcome").prepend("<strong>Welcome</strong> ");
                jQuery("#username").prepend('<strong>' + welcome + '</strong><span class="divider"></span>');
            } 

            // update link url
            jQuery("#loginLink a").text("Log on");
            jQuery("#loginLink a").attr("href", window.location.protocol + "//" + window.location.host + "/logon");

            window.bmcloggedon = false;


        } else {
            jQuery("#welcome").innerHTML = "";
            jQuery("#loginLink a").text("Log on");
            jQuery("#loginLink a").attr("href", window.location.protocol + "//" + window.location.host + "/logon");

            window.bmcloggedon = false;

        }


        // if athens login cookie doesn't exist and the athens login link is visible then remove it.
        if(allCookies.hasItem("athens") != true && document.getElementById("loginAthensLink") != null) {
          jQuery("#loginAthensLink").hide();
        }

}

login();


</script>

            <ul class="nav-sup">

    
        <li id="BMC" class="current">
            <a href="http://www.biomedcentral.com/"><span class="img-title">&nbsp;</span>
            <span class="text-title">BioMed Central</span></a>
        </li>
		
        		<li><a href="http://www.biomedcentral.com/journals"><span>Journals</span></a></li>
		
								<li>
				<a href="http://www.biomedcentral.com/gateways"><span>Gateways</span></a>
			</li>
					    	
</ul>
        </div>
    </div>
    <div class="branding-inner">

        

    
<style>
.survey {
	margin: 10px 0;
}
.survey, .survey .survey-sentence {
	font-size: 13px;
}
.survey-button a, .survey-button a:active, .survey-button a:visited, .survey-button a:hover  {
    color: #FFFFFF;
    text-decoration: none;
}
.survey-button {
	background-color: #FFA500;
    border-radius: 5px;
    color: #FFFFFF;
    font-weight: bold;
    font-size: 13px;
    font-weight: bold;
    padding: 5px 13px;
    background: #ef8142; /* Old browsers */
	background: -moz-linear-gradient(top,  #ef8142 0%, #ef8142 50%, #a64510 100%, #a64510 100%); /* FF3.6+ */
	background: -webkit-gradient(linear, left top, left bottom, color-stop(0%,#ef8142), color-stop(50%,#ef8142), color-stop(100%,#a64510), color-stop(100%,#a64510)); /* Chrome,Safari4+ */
	background: -webkit-linear-gradient(top,  #ef8142 0%,#ef8142 50%,#a64510 100%,#a64510 100%); /* Chrome10+,Safari5.1+ */
	background: -o-linear-gradient(top,  #ef8142 0%,#ef8142 50%,#a64510 100%,#a64510 100%); /* Opera 11.10+ */
	background: -ms-linear-gradient(top,  #ef8142 0%,#ef8142 50%,#a64510 100%,#a64510 100%); /* IE10+ */
	background: linear-gradient(to bottom,  #ef8142 0%,#ef8142 50%,#a64510 100%,#a64510 100%); /* W3C */
	filter: progid:DXImageTransform.Microsoft.gradient( startColorstr='#ef8142', endColorstr='#a64510',GradientType=0 ); /* IE6-9 */

}
</style>




          <div class="logo">
        <a href="/"><img alt="Trials" title="Trials Logo" src="/sites/10096/images/logo.gif" /></a>     
      </div>    
        
                    



            <div id="impact-factor" class="official">
    <img src="/images/branding/official.gif" alt="official impact factor" title="2.12"/>
    <span id="impact-factor-value">2.12</span>
</div>
    
                            

<div class="module search gray small  " role="search">
    <div class="module-inner padded">
        <form method="get" class="searchForm"
              action=" /quickSearchRedirectURL "
              onsubmit="window.location.href=this['url'].value + '?terms=' + encodeURIComponent(this['terms'].value); return false;">
            <fieldset class="search">
			                <span>
                    Search <select name="url">
                                <option value="http://www.trialsjournal.com/search/results" selected>Trials</option>
                                <option value="http://www.biomedcentral.com/search/results">BioMed Central</option>
                           </select> for
                </span>
                            <input id="searchTerms" name="terms" type="text" alt="Search terms" class="text " />
                 <button class="w37" value="Go" type="submit">Go</button>
            </fieldset>
        </form>
    </div>
	<a class="advanced-search" href="/search">Advanced search</a>
</div> 

                        <div id="mobile-nav-list" >

	<ul class="primary-nav" role="navigation">
		<li     ><a href="/"><span id="home-tab">Home</span></a></li>
														<li             class="current"
    ><a href="/content"><span id="articles-tab">Articles</span></a></li>
										
	

	
            <li     ><a href="/authors/instructions"><span id="authors-tab">Authors</span></a></li>
        <li     ><a href="/about/reviewers"><span id="reviewers-tab">Reviewers</span></a></li>
    		<li     ><a href="/about"><span id='about-tab'>About this journal</span></a></li>
	<li     ><a href="/my"><span id="my-tab">My Trials</span></a></li>
		
    		</ul>
</div>
            </div>
</div>

<hr class="hide" />
<div class="container">
	<div id="content"  class="overflow-visible"  role="main">
			    
	

<!--div class="branding-mobile">
		<h1 class="logo">
	    <a href="/">
		    <img alt="Trials" title="Trials Logo" src="/sites/10096/images/logo.gif" />
		</a>
		</h1>
	</div><br/-->



			
	



<div class="outline-wrapper block mobile-hidden" id="left-article-box">
<ul id="box-outline" class="box">
<ul id="outline" class="outline">
   <li>
      <a href="#">Top</a>
   </li>
   <li>
      <a href="#abs">Abstract</a>
   </li>
   <li>
      <a href="#sec1">Background</a>
   </li>
   <li>
      <a href="#sec2">Methods</a>
   </li>
   <li>
      <a href="#sec3">Results</a>
   </li>
   <li>
      <a href="#sec4">Discussion</a>
   </li>
   <li>
      <a href="#sec5">Conclusions</a>
   </li>
   <li>
      <a href="#sec6">Abbreviations</a>
   </li>
   <li>
      <a href="#sec7">Competing interests</a>
   </li>
   <li>
      <a href="#sec8">Authors’ contributions</a>
   </li>
   <li>
      <a href="#ack">Acknowledgments</a>
   </li>
   <li class="lowest">
      <a href="#refs">References</a>
   </li>
</ul>
</ul>

<dl id="box-outline1">
</dl>

				



</div>



<div class="mobile-hidden" id="right-panel">
 	
<div id="mobile-sidebar">
	<div id="mobile-sidebar-tab">
		<span>
			<a href="#" id="mobile-sidebar-tab-link"><img src="/images/sidebar-hidden.png"><img style="display:none;" src="/images/sidebar-shown.png"></a>
		</span>
	</div>	<div id="mobile-sidebar-list">

<div id="article-navigation-bar">
    <div class="issue-information block">
        <h5><a href="http://www.trialsjournal.com"><strong>Trials</strong></a></h5>
 		        <ul class="square normal">
            <li><a href="http://www.trialsjournal.com/content/16">Volume 16</a></li>
				
                    </ul>
    </div>

    <div class="article-information block" id="article-info">
        


<div id="viewing-options-links">
	<h5>Viewing options</h5>
	<ul class="square normal">
        
            <li>
                             <a onclick="_gaq.push(['_trackEvent', 'Abstract', 'Article Sidebar', '/content/16/1/15', 1, true]);" href="/content/16/1/15/abstract">Abstract</a>
                        </li>
        				<li>
							<strong>Full text</strong>
					</li>
				
		<li class="pdfFileSize">
			<a onclick="_gaq.push(['_trackEvent', 'PDF download', 'Article Sidebar', '/content/16/1/15', 1, true]);" href="/content/pdf/s13063-014-0535-7.pdf">PDF</a>
			<span>(758KB)</span>
		</li>

        
				<li>
						<a onclick="_gaq.push(['_trackEvent', 'additional files', 'Article Sidebar', '/content/16/1/15', 1, true]);" href="/content/16/1/15/additional">Additional files</a>
					</li>
			</ul>

        
</div>
		
<div id="associated-material-links">
    <h5>Associated material</h5>
    <ul class="square normal">
                        <li>
            <a onclick="_gaq.push(['_trackEvent', 'Pubmed record', 'Article Sidebar', '/content/16/1/15', 1, true]);" href="/pubmed/25592642">PubMed record</a>
        </li>
                            <li><a onclick="_gaq.push(['_trackEvent', 'Article metrics', 'Article Sidebar', '/content/16/1/15', 1, true]);" href="/content/16/1/15/about">Article metrics</a></li>
                <li>
                        <a onclick="_gaq.push(['_trackEvent', 'Readers comments', 'Article Sidebar', '/content/16/1/15', 1, true]);" href="/content/16/1/15/comments">Readers' comments </a>
                    </li>
        <li>
                            <a onclick="_gaq.push(['_trackEvent', 'Pre-publication history', 'Article Sidebar', '/content/16/1/15', 1, true]);" href="/content/16/1/15/prepub">Pre-publication history</a>                    </li>
    </ul>
</div>
		




<div id="related-literature-links">
    <h5>Related literature</h5>
    <ul class="normal">
                    <li><a onclick="_gaq.push(['_trackEvent', 'Citied by', 'Article Sidebar', '/content/16/1/15', 1, true]);" href="http://www.trialsjournal.com/content/16/1/15/about#citations">Cited by</a></li>
                <li id="google-blog-search"><a onclick="_gaq.push(['_trackEvent', 'Google blog search', 'Article Sidebar', '/content/16/1/15', 1, true]);" href="http://www.google.com/search?tbm=blg&hl=en&amp;source=hp&amp;biw=1280&amp;bih=899&amp;q=%22Improving+the+pre-screening+of+eligible+patients+in+order+to+increase+enrollment+in+cancer+clinical+trials%22&amp;btnG=Search">Google blog search</a></li>
        <h6>Other articles by authors</h6>
        <li>
            <a class="collapser"><i>&nbsp;</i>on Google Scholar</a>
<ul id="authg" class="hidebeforeload">                         <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22B+Campillo-Gimenez%22">Campillo-Gimenez B</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22C+Buscail%22">Buscail C</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22O+Zekri%22">Zekri O</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22B+Laguerre%22">Laguerre B</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22E+Le Prisé%22">Le Prisé E</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22R+De Crevoisier%22">De Crevoisier R</a>
            </li>
                                <li>
                <a href="http://scholar.google.com/scholar?q=author%3A%22M+Cuggia%22">Cuggia M</a>
            </li>
            </ul>          </li>
                <li>
            		<a class="collapser"><i>&nbsp;</i>on PubMed</a>
	<ul id="authpm" class="hidebeforeload"> 									<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Campillo-Gimenez_B%20[Author]">Campillo-Gimenez B</a>
				</li>
												<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Buscail_C%20[Author]">Buscail C</a>
				</li>
												<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Zekri_O%20[Author]">Zekri O</a>
				</li>
												<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Laguerre_B%20[Author]">Laguerre B</a>
				</li>
												<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Le_Prisé_E%20[Author]">Le Prisé E</a>
				</li>
												<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=De_Crevoisier_R%20[Author]">De Crevoisier R</a>
				</li>
												<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=Cuggia_M%20[Author]">Cuggia M</a>
				</li>
						</ul > 	        </li>
    </ul>     <h6>Related articles/pages</h6>
    <ul class="square normal">
        <li><a onclick="_gaq.push(['_trackEvent', 'on google', 'Article Sidebar', '/content/16/1/15', 1, true]);" href="http://www.google.co.uk/search?hl=en&amp;q=related:http://www.trialsjournal.com/content/16/1/15">on Google</a></li>
        <li><a onclick="_gaq.push(['_trackEvent', 'on google scholar', 'Article Sidebar', '/content/16/1/15', 1, true]);" href="http://scholar.google.com/scholar?q=related:http://www.trialsjournal.com/content/16/1/15">on Google Scholar</a></li>
                    <li><a onclick="_gaq.push(['_trackEvent', 'on Pubmed', 'Article Sidebar', '/content/16/1/15', 1, true]);" href="/pubmed/related/25592642">on PubMed</a></li>
            </ul>

</div>		
        
    
    
        

    	






<h5>Tools</h5>
	<ul class="square normal">
									<li>
						<a onclick="_gaq.push(['_trackEvent', 'download references', 'Article Sidebar', '/content/16/1/15', 1, true]);" href="/content/16/1/15/citation">Download references</a>
					</li>
				<li><a onclick="_gaq.push(['_trackEvent', 'download xml', 'Article Sidebar', '/content/16/1/15', 1, true]);" href="/content/download/xml/s13063-014-0535-7.xml">Download XML</a></li>
				<li>
						<a onclick="_gaq.push(['_trackEvent', 'email2friend', 'Article Sidebar', '/content/16/1/15', 1, true]);" href="/content/16/1/15/email">Email to a friend</a>
					</li>
		<li><a onclick="_gaq.push(['_trackEvent', 'order reprints', 'Article Sidebar', '/content/16/1/15', 1, true]);" href="https://www.odysseypress.com/onlinehost/reprint_order.php?type=A&page=0&journal=738&doi=10.1186/s13063-014-0535-7&volume=16&issue=1&title=Improving+the+pre-screening+of+eligible+patients+in+order+to+increase+enrollment+in+cancer+clinical+trials&author_name=Boris Campillo-Gimenez&start_page=1&end_page=10">Order reprints</a></li>
		<li>
						<a onclick="_gaq.push(['_trackEvent', 'post a comment', 'Article Sidebar', '/content/16/1/15', 1, true]);" href="/content/16/1/15/postcomment">Post a comment</a>
					</li>			
		<ul id="download-to-links">
			<a class="downloadto_title btn" href="#"><span class="icon">&nbsp;</span>Download to ...</a>
			
			<ul id="downloadto" class="iconlist hidebeforeload" style="display: none;">
				<li>
					<a href="http://redirect.papersapp.com/redirect?url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F16%2F1%2F15" target="_blank" onclick="_gaq.push(['_trackEvent', 'Download to Papers', 'Article Sidebar', '/content/16/1/15', 1, true]);"><span class="share-icons papers"></span>Papers</a>
				</li>
				<li>
					<a href="http://www.mendeley.com/import/?url=http://www.trialsjournal.com/content/16/1/15" target="_blank" onclick="_gaq.push(['_trackEvent', 'Download to Mandeley', 'Article Sidebar', '/content/16/1/15', 1, true]);"><span class="share-icons mendeley"></span>Mendeley</a>
				</li>
			</ul>
		</ul>
		
		<ul id="mobile-downloadto" class="iconlist">
		
		<h6>Download to ...</h6>
			<li>
				<a href="http://redirect.papersapp.com/redirect?url=http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F16%2F1%2F15" target="_blank" onclick="_gaq.push(['_trackEvent', 'Download to Papers', 'Article Sidebar', '/content/16/1/15', 1, true]);"><span class="share-icons papers"></span>Papers</a>
			</li>
			
			<li>
				<a href="http://www.mendeley.com/import/?url=http://www.trialsjournal.com/content/16/1/15" target="_blank" onclick="_gaq.push(['_trackEvent', 'Download to Mandeley', 'Article Sidebar', '/content/16/1/15', 1, true]);"><span class="share-icons mendeley"></span>Mendeley</a>
			</li>
		</ul>

		
	</ul>
		




<h5>Share this article</h5>
<ul id="social-networking-links">
	<li>
	<div class="fb-like" onclick="_gaq.push(['_trackEvent', 'Facebook Recommend', 'Article Sidebar', '/content/16/1/15', 1, true]);" data-href="http://www.trialsjournal.com/content/16/1/15" data-send="false" data-layout="button_count" data-width="100" data-show-faces="false" data-action="recommend"></div>
	</li>
	<li>
		<a onclick="_gaq.push(['_trackEvent', 'Share Twitter Recommend', 'Article Sidebar', '/content/16/1/15', 1, true]);" href="http://twitter.com/share" data-url="http://www.trialsjournal.com/content/16/1/15" data-counturl="http://www.trialsjournal.com/content/16/1/15" data-hashtags="trials
" data-text="Improving the pre-screening of eligible patients in order to increase enrollment in cancer clinical trials" class="twitter-share-button">Tweet</a>
	</li>
	<li>
			<g:plusone size="medium" width="100"></g:plusone>
	</li>

        <li>
        <wb:share-button onclick="_gaq.push(['_trackEvent', 'Recommend Google plus', 'Article Sidebar', '/content/16/1/15', 1, true]);" addition="number" type="button" ralateUid="2216240737" title="Improving the pre-screening of eligible patients in order to increase enrollment in cancer clinical trials http://www.trialsjournal.com/content/16/1/15"></wb:share-button>
    </li>
    
		<a class="sharethis_title btn" href="#"><span class="icon">&nbsp;</span>More options...</a>
	<ul class="iconlist hidebeforeload" id="sharethis">
			<li>
				<a target="_blank" onclick="_gaq.push(['_trackEvent', 'citeu Like', 'Article Sidebar', '/content/16/1/15', 1, true]);" href="http://www.citeulike.org/posturl?url=http://www.trialsjournal.com/content/16/1/15"><span class="share-icons citeulike"></span>Citeulike</a>
			</li>
				<li>
			<a target="_blank" onclick="_gaq.push(['_trackEvent', 'Share Linkedin', 'Article Sidebar', '/content/16/1/15', 1, true]);" href="http://www.linkedin.com/shareArticle?mini=true&url=%26%2335%3Btrials%0D%0AImproving%20the%20pre-screening%20of%20eligible%20patients%20in%20order%20to%20increase%20enrollment%20in%20cancer%20clinical%20trials%20http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F16%2F1%2F15&title=Improving the pre-screening of eligible patients in order to increase enrollment in cancer clinical trials"><span class="share-icons linkedin"></span>LinkedIn</a>
	</li>
			<li>
				<a target="_blank" onclick="_gaq.push(['_trackEvent', 'Share delicious', 'Article Sidebar', '/content/16/1/15', 1, true]);" href="http://del.icio.us/post?url=http://www.trialsjournal.com/content/16/1/15&title=Improving the pre-screening of eligible patients in order to increase enrollment in cancer clinical trials"><span class="share-icons delicious"></span>Del.icio.us</a>
	</li>
			<li>
				<a onclick="_gaq.push(['_trackEvent', 'Share via email', 'Article Sidebar', '/content/16/1/15', 1, true]);" href="/content/16/1/15/email"><span class="share-icons email"></span>Email</a>
	</li>
			<li>
				<a onclick="target="_blank" onclick="_gaq.push(['_trackEvent', 'Share facebook', 'Article Sidebar', '/content/16/1/15', 1, true]);" href="http://www.facebook.com/sharer.php?u=http://www.trialsjournal.com/content/16/1/15"><span class="share-icons facebook"></span>Facebook</a>
	</li>
	<li class="gp">
			<div class="googlehider mobile-hide"> 
				<div class="g-plusone" data-annotation="none"></div>
			</div>
				<span class="share-icons googleplus mobile-hide"></span>
				<div class="googlehider2 mobile-hide"> 
				<div class="g-plusone mobile-hide" data-annotation="none"></div>
			</div>
				<span class="share-icons googleplus"></span>
				<span class="gp-link"><a  onclick="_gaq.push(['_trackEvent', 'Share google plus', 'Article Sidebar', '/content/16/1/15', 1, true]);" href="#">Google+</a></span>
	</li>
			<li>
				<a target="_blank" onclick="_gaq.push(['_trackEvent', 'Share Mandeley', 'Article Sidebar', '/content/16/1/15', 1, true]);" href="http://www.mendeley.com/import/?url=http://www.trialsjournal.com/content/16/1/15"><span class="share-icons mendeley"></span>Mendeley</a>
			</li>
			<li>
			<a target="_blank" onclick="_gaq.push(['_trackEvent', 'Share twitter icon', 'Article Sidebar', '/content/16/1/15', 1, true]);" href="http://twitter.com/?status=Improving%20the%20pre-screening%20of%20eligible%20patients%20in%20order%20to%20increase%20enrollment%20in%20cancer%20clinical%20trials%20http%3A%2F%2Fwww.trialsjournal.com%2Fcontent%2F16%2F1%2F15+%23trials
"><span class="share-icons twitter"></span>Twitter</a>
			</li>

			<li><a href="http://www.reddit.com/submit" onclick="window.location = 'http://www.reddit.com/submit?url=http://www.trialsjournal.com/content/16/1/15'; return false"> <span class="share-icons reddit"></span>Reddit</a>
    </li>






		</ul>
</ul>

    </div>

    
  
        
                
        


















                                                                                
	

	    
   
  
      
  
                  
  
                  
  
            
  
            
            

<div id="signup-to-etoc" class="button-collection-margins block mobile-border-bottom">	
					<h3>Email updates</h3>
			<p id="receive_issue_alerts_journal_updates_text">Keep up to date with the latest news and content from Trials and BioMed Central.</p>
			
				
<form  id="articleSignupForUpdates"  method="post" action="/signuptoupdates.html">
	<div id="message-box"></div>
    <fieldset class="block-form">
        <input type="text" name="emailAddress" onblur="javascript: if (this.value == '') { this.value = 'email address'; }" onfocus="javascript: if (this.value == 'email address') { this.value = ''; }" value="email address"  class="text " id="email" />
        <input value="" type="hidden" name="returnUrl" id="returnUrl" />
        <input value="xniche-trials" type="hidden" name="listName" id="listName" />
        <input value="Trials" type="hidden" name="journalName" id="journalName" />
        <button onclick="_gaq.push('_trackEvent', 'Signup', 'Signup for Email updates', "Trials");" class="w74 right" type="submit" onmouseover="this.className='w74 hover right'" onmouseout="this.className='w74 right'" value="Sign up">Sign up</button>
    </fieldset>
</form>	
</div>

	


			<div id="advert-offset">
    					
		<dl class="google-ad  ">
	<dt class="hide">
				
					<a class="skyscraper-ad" href="http://www.biomedcentral.com/advertisers/digital_advertising">Advertisement</a>
			</dt>
		<dd>

		<!-- OAS AD 'Right3' begin -->
		<script type="text/javascript">
		OAS_AD('Right3');

		</script>
		<!-- OAS AD 'Right3' end -->
		</dd>

		</dl>

		<noscript>
			<dl class="google-ad  noscript">  
    <dt class="hide"><a href="http://www.biomedcentral.com/advertisers/digital_advertising">Advertisement</dt>
    
    <dd>
        <a href="//oas.biomedcentral.com/RealMedia/ads/click_nx.ads/trialsjournal.com/article/10.1186/s13063/014/0535/7/12579101180@Right3?">
            <img src="//oas.biomedcentral.com/RealMedia/ads/adstream_nx.ads/trialsjournal.com/article/10.1186/s13063/014/0535/7/12178796932@Right3?" alt="advert"/>
        </a>
    </dd>
			</dl>
		</noscript>
					</div>
	

	
</div>
		<div class="mobile-sidebar-gradient top"></div>
		<div class="mobile-sidebar-gradient bottom"></div>
	</div>

</div>








 </div>
<div class="rounded custom white article full-text">
<div class="wrap-inner content">
    <div class="padded-inner">            


    
   
  
      
  
                  
  
                  
  
            
  
            
            

<div id="topmatter">
	


	   






 
  



				<a href="/about/access"><img alt="Open Access" src="/images/articles/openaccess-large.png" class="access mr15"/></a>
					<span class="articletype">Research</span>

<h1>Improving the pre-screening of eligible patients in order to increase enrollment in cancer clinical trials</h1>
        
			<div class="multipleins">
		
	<p class="authors">
        																																																																																																																																																																																																																																				         <strong>Boris Campillo-Gimenez</strong><sup><a href="/content/16/1/15/#ins1">1</a></sup><sup>&#42;</sup>, <strong>Camille Buscail</strong><sup><a href="/content/16/1/15/#ins2">2</a></sup>, <strong>Oussama Zekri</strong><sup><a href="/content/16/1/15/#ins3">3</a></sup>, <strong>Brigitte Laguerre</strong><sup><a href="/content/16/1/15/#ins3">3</a></sup>, <strong>Elisabeth Le Prisé</strong><sup><a href="/content/16/1/15/#ins3">3</a></sup>, <strong>Renaud De Crevoisier</strong><sup><a href="/content/16/1/15/#ins3">3</a></sup> and <strong>Marc Cuggia</strong><sup><a href="/content/16/1/15/#ins1">1</a></sup><sup><a href="/content/16/1/15/#ins4">4</a></sup>	</p>
	
				<div id="affiliations">
		<div class="module gray  inner">
<div class="module-inner padded-inner">
		<ul>
			<li>                        
                                                                                                    		<p class="authors" >
							<span>*</span>
									 Corresponding author:										            Boris  Campillo-Gimenez <a href='mailto:boris.campillo-gimenez@univ-rennes1.fr'>boris.campillo-gimenez@univ-rennes1.fr</a>    					</p>
      
</li>
			
                                                                                                                                                                                                                    		</ul>

		
		 <p class="options"><a class="affiliations-toggle" href="#"><i class="arrow"></i>Author Affiliations</a></p>            <section> 
						<div class="collapsible-content">
							
				<div id="ins_container" style="display: block;">
										    						    <p >
						        <sup id="ins1">1</sup>                                Inserm U1099 - LTSI, Equipe Données Massives en Santé - Université Rennes 1, 2 rue du Professeur Léon Bernard, Rennes Cedex, 35043, France
                            </p>
																    						    <p >
						        <sup id="ins2">2</sup>                                Department of Medical Information, University Hospital of Rennes, 2 rue Henri Le Guilloux, Rennes, 35000, France
                            </p>
																    						    <p >
						        <sup id="ins3">3</sup>                                Comprehensive Cancer Center Eugene Marquis (CCC), Avenue de la Bataille Flandres-Dunkerque, Rennes Cedex, 35042, France
                            </p>
																    						    <p >
						        <sup id="ins4">4</sup>                                Clinical Investigation Center, University Hospital of Rennes, 2 rue du Professeur Léon Bernard, Rennes Cedex, 35043, France
                            </p>
																
				</div>
										<p id="authoremails">            For all author emails, please <a href="/logon">log on</a>.
    </p>
						</div>
			</section>
				</div>
</div>
		</div>
	  </div>

            <section class="cit">
                        <div class="collapsible-content">
        <p><em>Trials</em> 2015, <strong>16</strong>:15&nbsp;
			<span class="pseudotab">doi:10.1186/s13063-014-0535-7</span></p>
	    				    
    
        
                
		<p>The electronic version of this article is the complete one and can be found online at: <a href="http://www.trialsjournal.com/content/16/1/15">http://www.trialsjournal.com/content/16/1/15</a></p>
		<br/>
                    <table cellspacing="0" cellpadding="0">
        <tbody>
        <tr><td>Received:</td><td>9 April 2014</td></tr>                <tr><td>Accepted:</td><td>19 December 2014</td></tr>        <tr><td>Published:</td><td>16 January 2015</td></tr>        </tbody>
        </table>
    		<!--<br/>-->
		<div  style="line-height:140%">
        <p>
            &copy; 2015 Campillo-Gimenez et al.; licensee BioMed Central. <br />
        </p>
					<p>
				This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<a href='http://creativecommons.org/licenses/by/4.0'>http://creativecommons.org/licenses/by/4.0</a>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
			</p>
		    	</div>
	</section>

</div>
<div id="article-body">
    <section><a name="abs"></a><h3>Abstract</h3>
   <div class="collapsible-content">
      <h4>Background</h4>
      <p style="line-height:160%">The performance of randomized controlled trials (RCTs) is often hindered by recruitment
         difficulties. This study aims to explore the pre-screening phase of four prostate
         cancer RCTs to identify the impact of a systematic pre-selection of eligible patients
         for RCT recruitment.
      </p>
      <h4>Methods</h4>
      <p style="line-height:160%">The pre-screening of four RCTs opened at the Comprehensive Cancer Center in Rennes
         was analyzed retrospectively (French Genitourinary Tumor Group (GETUG) 14, 15, 16,
         and 17). Data were extracted from electronic multidisciplinary cancer (MDC) reports
         and manually completed by physicians and medical secretaries. These data were the
         main source of information for clinicians to discuss treatment alternatives during
         MDC sessions. The pre-screening decisions made by the clinicians during these MDC
         meetings were compared with those made after a systematic review of the MDC reports
         by a clinical research assistant (CRA). Any inconsistencies in decisions between the
         CRA and the MDC physicians were corrected by the principal investigator (PI).
      </p>
      <h4>Results</h4>
      <p style="line-height:160%">The pre-screening rate was 9.1% during the MDC meetings, while it was estimated to
         be 12.9% after the final review by the PI, and 29% after the systematic review by
         the CRA. The study showed that 77% and 67% of the MDC reports did not mention clinical
         and pathological Tumor, lymph node and metastasis classification of malignant tumors
         (TNM) staging, respectively, and that 35 of the CRA’s 47 proposals rejected by the
         PI concerned implicit information (not specified in the MDC reports). Only one patient
         was proposed by the PI, and none by the CRA.
      </p>
      <h4>Conclusions</h4>
      <p style="line-height:160%">These results confirm that pre-screening could be improved by a systematic review
         of the medical reports. They also highlight the fact that missing data in electronic
         MDC reports leads to over-enrollment of non-eligible patients, but not to over-exclusion
         of eligible patients. Thus, our study confirms the potential gain in using semi-automated
         pre-selection of MDC reports, in order to avoid missing out on patients eligible for
         RCTs.
      </p>
      <h4>Trial registration</h4>
      <p style="line-height:160%">The trials evaluated in this study were previously registered with clinicaltrials.gov
         (registration number: <a href="NCT00104741">NCT00104741</a> <a href="http://www.webcitation.org/query.php?url=NCT00104741&amp;refdoi=10.1186/s13063-014-0535-7" alt="" title="Archive copy of webpage" class="xpushbutton">webcite</a> on 3 March 2005; <a href="NCT00104715">NCT00104715</a> <a href="http://www.webcitation.org/query.php?url=NCT00104715&amp;refdoi=10.1186/s13063-014-0535-7" alt="" title="Archive copy of webpage" class="xpushbutton">webcite</a> on 3 March 2005; <a href="NCT00423475">NCT00423475</a> <a href="http://www.webcitation.org/query.php?url=NCT00423475&amp;refdoi=10.1186/s13063-014-0535-7" alt="" title="Archive copy of webpage" class="xpushbutton">webcite</a> on 16 January 2007; and <a href="NCT00667069">NCT00667069</a> <a href="http://www.webcitation.org/query.php?url=NCT00667069&amp;refdoi=10.1186/s13063-014-0535-7" alt="" title="Archive copy of webpage" class="xpushbutton">webcite</a> on 24 April 2008).
      </p>
   </div>
</section><span id="keywords">
   <h5 class="inline">Keywords: </h5>Prostatic neoplasms; Randomized controlled trials as a topic; Patient selection; Decision support systems; Clinical; Patient pre-screening</span><section><a name="sec1"></a><h3>Background</h3>
   <div class="collapsible-content">
      <p style="line-height:160%">The randomized controlled trial (RCT) is the gold standard for evaluating the effects
         of healthcare procedures, but the performance of clinical RCTs is often hindered by
         recruitment difficulties <a name="d73120e208"></a>[<a onclick="LoadInParent('#B1'); return false;" href="#B1">1</a>]. Inadequate recruitment causes delays, increases costs, reduces the statistical power
         of analysis and finally, may lead to failed clinical trials.
      </p>
      <p style="line-height:160%">Clinical trials are an important option of care for cancer patients since they often
         provide the most up-to-date and effective treatment for end-stage disease. It has
         also been suggested that more participation in oncology clinical trials could lead
         to improved survival in cancer patients <a name="d73120e214"></a>[<a onclick="LoadInParent('#B2'); return false;" href="#B2">2</a>],<a name="d73120e218"></a>[<a onclick="LoadInParent('#B3'); return false;" href="#B3">3</a>]. Nevertheless, patient enrollment remains particularly low in oncology clinical trials
         (according to the National Cancer Institute, less than 5% of adults with incident
         cancer participate in clinical trials in the United States) <a name="d73120e222"></a>[<a onclick="LoadInParent('#B4'); return false;" href="#B4">4</a>],<a name="d73120e226"></a>[<a onclick="LoadInParent('#B5'); return false;" href="#B5">5</a>].
      </p>
      <p style="line-height:160%">Barriers to recruitment for oncology clinical trials can be summarized into three
         main categories <a name="d73120e232"></a>[<a onclick="LoadInParent('#B6'); return false;" href="#B6">6</a>],<a name="d73120e236"></a>[<a onclick="LoadInParent('#B7'); return false;" href="#B7">7</a>]:
      </p>
      <p style="line-height:160%"> Individual barriers (such as patients feeling uncomfortable with experimentation
         or experiencing a loss of control over decision-making, and physician time and effort
         required for recruitment),
      </p>
      <p style="line-height:160%"> Barriers related to RCT designs (overly strict or non-adapted criteria, too large
         a number of RCTs, RCT complexity leading to difficulties in explaining trials to patients,
         and so forth), and
      </p>
      <p style="line-height:160%"> Barriers caused by system and organizational features (lack of staff and research
         nurses, communication difficulties, planning of local resources according to RCT designs,
         and so forth).
      </p>
      <p style="line-height:160%">Different strategies, often timesaving and cost-effective, can be used to overcome
         these barriers (for example, hiring a research nurse or a data manager). But there
         is also evidence that Health Information Systems and Information Technologies can
         improve the recruitment process. A review of recent literature shows that many studies
         examine, discuss, and/or deal with support systems for clinical trial recruitment
         <a name="d73120e248"></a>[<a onclick="LoadInParent('#B5'); return false;" href="#B5">5</a>]. These are mainly concerned with addressing individual barriers, and sometimes with
         the development of tools to ease usability of eligibility criteria. However, the authors
         highlight the lack of evaluation and workflow integration of the support systems into
         the RCT recruitment process, and they emphasize the importance of the pre-screening
         phase for recruitment, particularly for RCT recruitment systems.
      </p>
      <p style="line-height:160%">In this study, we hypothesized that the improvement of pre-screening of patients eligible
         for RCTs would lead to an improvement in overall patient enrollment in clinical trials.
         Thus, the study focused on the pre-screening steps of patient enrollment to RCTs.
      </p>
      <p style="line-height:160%">The main objective of the present study was to assess the impact of semi-automated
         decision support systems in improving patient pre-screening in oncology RCTs. Therefore,
         the study compared the pre-screening decisions made prospectively by the physicians
         during patient care, with the pre-screening decisions made with a systematic and retrospective
         review of the medical reports. Then, the study identified factors that could make
         pre-screening more efficient.
      </p>
   </div>
</section>
<section><a name="sec2"></a><h3>Methods</h3>
   <div class="collapsible-content">
      <h4>Workflow of multidisciplinary cancer meetings</h4>
      <p style="line-height:160%">As presented in Figure&nbsp;<a name="d73120e265"></a><a onclick="popup('http://www.trialsjournal.com/content/16/1/15/figure/F1','',800,470); return false;" href="http://www.trialsjournal.com/content/16/1/15/figure/F1">1</a>, multidisciplinary cancer (MDC) meetings (MDMs) are the start of patient management
         in oncology and often the first step leading to patient enrollment in cancer RCTs,
         known as the pre-screening phase.
         
      </p><div class="figs">
      <div class="fig"><p><a onclick="popup('http://www.trialsjournal.com/content/16/1/15/figure/F1','F1',800,470); return false;" href="http://www.trialsjournal.com/content/16/1/15/figure/F1"><img align="top" src="/content/figures/s13063-014-0535-7-1.gif" alt="thumbnail" class="thumbnail"><strong>Figure 1.</strong></a> <strong>The therapeutic decision-making process for patients with cancer in Brittany (France),
            including the multidisciplinary cancer (MDC) meeting.</strong> Step one: MDC meeting request by a treating physician concerning a patient; step
         two: MDC meeting scheduled by the MDC secretary; step three: presentation of the MDC
         report during the MDC meeting; step four: registration of the therapeutic decision
         in the oncologic electronic health records (EHR) and feedback to the treating physician.
      </div></div>
      <p style="line-height:160%">In Brittany (France), the workflow starts with a request made by the treating physician
         to the MDC secretary, in order to schedule the presentation of the patient’s case
         within the MDM (steps one and two). With the patient data provided by the treating
         physician (most of the time from the paper-based patient record), the secretary fills
         in an online standard MDC report designed for each type of cancer. The MDC report
         is intended to collect all essential patient data to make the decision during the
         MDM.
      </p>
      <p style="line-height:160%">On the day of the MDM, the secretary shows each MDC report to the tumor board (step
         three). After the discussion, the therapeutic decision is registered (step four) and
         sent back to the treating physician who can then inform the patient.
      </p>
      <p style="line-height:160%">During the MDM, some patients may be proposed (in a pre-screening phase) as being
         potentially eligible for an RCT; according to a subset of selection criteria called
         that we will call ‘pre-screening criteria’. These criteria correspond to those that
         can be checked from the retrospective data available in the patient charts. Pre-screening
         criteria include, for instance, demographic characteristics (such as age and gender)
         and some medical characteristics (such as tumor stage and surgical history). The other
         criteria (which we will call ‘screening criteria’) are those that can only be tested
         secondarily (in a screening phase), after having contacted the patient (for example,
         a negative HIV test on the day of enrollment). The patients are eventually included
         in the appropriate RCT when all eligibility criteria are met.
      </p>
      <p style="line-height:160%">The present study proposes to retrospectively analyze the decision-making process
         of the MDM and to compare it to a systematic review of the patient’s case.
      </p>
      <h4>Focus on the ongoing randomized controlled trials used for the study</h4>
      <p style="line-height:160%">Urologic oncology was chosen as the experimental field for practical reasons, partly
         because most eligibility criteria are readily handled by computerized data (Tumor,
         lymph node and metastasis classification of malignant tumors (TNM) staging, the Gleason
         score, prostate-specific antigen (PSA) level, and so forth). The study focused on
         prostate cancer, which is the most common form in urology. It is also the main topic
         of discussion at urology MDMs and of many clinical trials.
      </p>
      <p style="line-height:160%">Four prostate cancer clinical trials were active and recruiting patients at the Cancer
         Research Institute of Rennes during the study period (between October 2008 and March
         2009), all conducted by the French Genitourinary Tumor Group (GETUG) <a name="d73120e298"></a>[<a onclick="LoadInParent('#B8'); return false;" href="#B8">8</a>]:
      </p>
      <p style="line-height:160%"><small>GETUG 14, </small>comparing triptorelin, flutamide, and external-beam radiation therapy to external-beam
         radiation therapy alone in treatment of patients with stage II or stage III prostate
         cancer (Clinicaltrials.gov identifier: NCT00104741);
      </p>
      <p style="line-height:160%"><small>GETUG 15, </small>comparing hormone therapy and docetaxel to hormone therapy alone in treatment of patients
         with metastatic prostate cancer (Clinicaltrials.gov identifier: NCT00104715);
      </p>
      <p style="line-height:160%"><small>GETUG 16, </small>comparing radiation therapy and goserelin to radiation therapy alone in treatment
         of patients who have undergone surgery for recurrent or refractory prostate cancer
         (Clinicaltrials.gov identifier: NCT00423475);
      </p>
      <p style="line-height:160%"><small>GETUG 17, </small>comparing immediate triptorelin and radiation therapy after surgery to the delayed
         treatment of patients who have undergone surgery for intermediate-risk stage III or
         stage IV prostate cancer (Clinicaltrials.gov identifier: NCT00667069).
      </p>
      <p style="line-height:160%">Detailed eligibility criteria for the four RCTs discussed at the MDMs during the study
         period are presented in Table&nbsp;<a name="d73120e319"></a><a onclick="popup('http://www.trialsjournal.com/content/16/1/15/table/T1','',800,470); return false;" href="http://www.trialsjournal.com/content/16/1/15/table/T1">1</a>. The RCTs were conducted in accordance with the Declaration of Helsinki. All participants
         were required to give written informed consent before enrollment in one of the four
         studies.
         
      </p><div class="figs">
      <div class="table"><p><a onclick="popup('http://www.trialsjournal.com/content/16/1/15/table/T1','T1',800,470); return false;" href="http://www.trialsjournal.com/content/16/1/15/table/T1"><strong>Table 1.</strong></a> <strong>Eligibility criteria of GETUG 14, GETUG 15, GETUG 16, and GETUG 17 clinical trials</strong></div></div>
      <h4>Data collection</h4>
      <p style="line-height:160%">The data used in our study consisted of the information contained in the MDC reports,
         and of the corresponding therapeutic decisions taken during the MDMs. The MDC reports
         included general characteristics of patients, medical history, and data related to
         prostate cancer, such as the Gleason score, tumor staging (clinical and pathological
         TNM classification), and the prostate-specific antigen (PSA) level. According to each
         case, the MDC team’s decisions were either to propose a standard therapy to the patient,
         or to participate in a clinical trial (in this case, the MDC team had estimated that
         pre-screening criteria seemed to be verified). MDC reports and MDM decisions were
         retrospectively and exhaustively collected. The data extraction (Figures&nbsp;<a name="d73120e975"></a><a onclick="popup('http://www.trialsjournal.com/content/16/1/15/figure/F1','',800,470); return false;" href="http://www.trialsjournal.com/content/16/1/15/figure/F1">1</a> and <a name="d73120e978"></a><a onclick="popup('http://www.trialsjournal.com/content/16/1/15/figure/F2','',800,470); return false;" href="http://www.trialsjournal.com/content/16/1/15/figure/F2">2</a>) corresponded to a period of six months while patient recruitment for the four prostate
         cancer RCTs was occurring.
         
      </p><div class="figs">
      <div class="fig"><p><a onclick="popup('http://www.trialsjournal.com/content/16/1/15/figure/F2','F2',800,470); return false;" href="http://www.trialsjournal.com/content/16/1/15/figure/F2"><img align="top" src="/content/figures/s13063-014-0535-7-2.gif" alt="thumbnail" class="thumbnail"><strong>Figure 2.</strong></a> <strong>Evaluation design of the multidisciplinary cancer (MDC) team’s pre-screening decisions.</strong> Step one: extraction of the MDC reports from the oncologic electronic health records
         (her); step two: Extraction of the MDC team’s pre-screening decisions from the oncologic
         EHR; Step 3: systematic review of the MDC reports by the clinical research assistant
         (CRA); step four: comparison of the pre-screening decisions made by the CRA and the
         MDC team; step five: principal investigator’s review of the MDC reports corresponding
         to the discrepancies between the CRA’s decisions and the MDC team’s decisions; step
         six: final pre-screening decisions (gold standard) including the principal investigator’s
         decisions.
      </div></div>
      <p style="line-height:160%">Data were completed with the number of medical records and the number of prostate
         cancer records discussed at each MDC meeting, as well as the number of physicians
         who participated in the MDMs.
      </p>
      <h4>Ethical statement</h4>
      <p style="line-height:160%">The local ethics committee, ‘Comité d’éthique du CHU de Rennes’, approved the present
         study (registration identifier: 13–26). All four trials cited in this study obtained
         ethical approval by a research ethics committee with the following approval numbers
         for GETUG 14: 2003/015 (CPPRB Haute Normandie), for GETUG 15: 04/08 (CPPRB Marseille
         1), GETUG 16: 06/025 (CPPRB Lyon), GETUG 17: 2007/53 (CPP Sud-Ouest et Outre Mer III).
      </p>
      <h4>Evaluation and statistical analysis</h4>
      <p style="line-height:160%">The evaluation protocol consisted in collecting and comparing three types of decision
         (MDC, clinical research assistant (CRA), and principal investigator (PI)). The MDC
         team’s decision was the initial tumor board’s decision made directly during the MDM.
      </p>
      <p style="line-height:160%">The CRA’s decision (Figure&nbsp;<a name="d73120e1010"></a><a onclick="popup('http://www.trialsjournal.com/content/16/1/15/figure/F2','',800,470); return false;" href="http://www.trialsjournal.com/content/16/1/15/figure/F2">2</a>, step three) was obtained by asking a CRA experienced in recruitment to clinical
         trials to systematically review all the MDC reports (while ensuring to hide the MDC
         team’s decision). Thus, the CRA only had access to information explicitly contained
         in the MDC reports; the CRA did not have any knowledge or information about the patients
         other than MDC reports and was unaware of MDC decisions. The MDC decisions and CRA’s
         decisions were compared (Figure&nbsp;<a name="d73120e1013"></a><a onclick="popup('http://www.trialsjournal.com/content/16/1/15/figure/F2','',800,470); return false;" href="http://www.trialsjournal.com/content/16/1/15/figure/F2">2</a>, step four). A PI reviewed the MDC reports corresponding to the discrepancies between
         the CRA’s decisions and MDM decisions (Figure&nbsp;<a name="d73120e1016"></a><a onclick="popup('http://www.trialsjournal.com/content/16/1/15/figure/F2','',800,470); return false;" href="http://www.trialsjournal.com/content/16/1/15/figure/F2">2</a>, steps five and six). In our study, we considered the PI’s decision (Figure&nbsp;<a name="d73120e1019"></a><a onclick="popup('http://www.trialsjournal.com/content/16/1/15/figure/F2','',800,470); return false;" href="http://www.trialsjournal.com/content/16/1/15/figure/F2">2</a>, step six) as being the best gold standard as the PI is the person the most involved
         in clinical trial recruitment.
      </p>
      <p style="line-height:160%">Results were described using means associated with standard deviations (<em>m ± ε</em>), and absolute and relative frequencies (n (%)). The MDC, CRA, and PI pre-screening
         decisions were described especially by the MDC, CRA and PI pre-screening rate, and
         compared using the McNemar’s chi-square test. Factors that could influence the MDC
         team’s pre-screening decisions (the characteristics of the MDMs and the content of
         the MDC reports) were tested using the Pearson’s correlation test and the Mann–Whitney
         U test.
      </p>
      <p style="line-height:160%">A descriptive analysis of the discrepancies between the MDC, CRA, and PI proposals
         was also performed. Statistical analysis was performed using R software, R Foundation
         for Statistical Computing, Vienna, Austria <a name="d73120e1030"></a>[<a onclick="LoadInParent('#B9'); return false;" href="#B9">9</a>]. Two-tailed <em>P</em> values were reported with <em>P</em> &lt;0.05 considered to be statistically significant.
      </p>
   </div>
</section>
<section><a name="sec3"></a><h3>Results</h3>
   <div class="collapsible-content">
      <h4>Description of the multidisciplinary cancer meetings and the multidisciplinary cancer
         reports
      </h4>
      <p style="line-height:160%">During the study period, 23 urologic MDMs were held at the Comprehensive Cancer Center
         of Rennes, and 466 MDC reports were analyzed. Among them, 286 MDC reports concerned
         patients with prostate cancer, all of which were evaluated in the present study.
      </p>
      <p style="line-height:160%">On average, 7 ± 1.7 physicians, including 3 ± 0.9 oncologists, attended each MDM.
         The PI of GETUG 14 was present at 12 of the 23 MDMs held during the study period,
         the PI of GETUG 15 at 15 of the 23 MDMs, the PI of GETUG 16 at 12 of the 23 MDMs,
         and the PI of GETUG 17 at 13 of the 23 MDMs.
      </p>
      <p style="line-height:160%">On average, during an MDM, 20 ± 6.2 reports were discussed with 12 ± 4.6 of those
         being related to patients with prostate cancer. Clinical and pathological TNM stages
         were found in 67 (23.4%) and 94 (32.9%) of the 286 MDC reports, respectively concerning
         patients with prostate cancer. However, 261 (91.3%) and 252 (88.1%) of the 286 MDC
         reports included the Gleason score and the PSA level, respectively.
      </p>
      <h4>Factors influencing the MDC team’s pre-screening decisions in GETUG 14, 15, 16 and
         17
      </h4>
      <p style="line-height:160%">A total of 26 patients were proposed for screening by the physicians who participated
         in the MDMs; 17 for screening in GETUG 14, seven for screening in GETUG 16 and two
         for screening in GETUG 17. No patient was proposed for screening in GETUG 15.
      </p>
      <p style="line-height:160%">Among factors that may have influenced pre-screening during the MDMs (the MDC team’s
         decisions), a statistically significant and negative correlation was found between
         the number of MDC reports concerning patients with prostate cancer and the pre-screening
         rate of each MDM (Pearson correlation coefficient (r) = −0.42, <em>P</em> = 0.046). There was also a reverse correlation between the overall number of MDC
         reports discussed in MDMs and the pre-screening rates of the MDMs, but this negative
         correlation was not found to be significant (r = −0.37, <em>P</em> = 0.082). The number of physicians and the number of oncologists attending the MDMs
         did not significantly influence the pre-screening rates (<em>P</em> = 0.521 and <em>P</em> = 0.964, respectively). Neither did the presence of the PI, whatever the RCT (GETUG
         14: <em>P</em> = 0.095, GETUG 15: no initial pre-screening proposal, GETUG 16: <em>P</em> = 0.550, GETUG 17: <em>P</em> = 0.950).
      </p>
      <p style="line-height:160%">Absence of (clinical and pathological) TNM staging, the Gleason Score, or the PSA
         level in the MDC reports did not hinder MDM attenders to make pre-screening decisions,
         and did not significantly influence the pre-screening rate of the MDC team (data not
         shown).
      </p>
      <h4>Pre-screening rates based on the multidisciplinary cancer team’s, clinical research
         assistants, and PI’s decisions
      </h4>
      <p style="line-height:160%">In total, 146 cumulative MDC report selections were recorded, concerning 86 different
         patients eligible for at least one RCT. GETUG 14 was the RCT with the most selections
         during the pre-screening period, with 106 (72.6%) proposals concerning 60 (69.8%)
         different patients. Pre-screening rates related to each RCT, according to the MDC
         team’s, CRA’s, and PI’s decisions, are reported in Table&nbsp;<a name="d73120e1091"></a><a onclick="popup('http://www.trialsjournal.com/content/16/1/15/table/T2','',800,470); return false;" href="http://www.trialsjournal.com/content/16/1/15/table/T2">2</a>. The overall pre-screening rates were estimated at 9.1% (26 patients) based on the
         MDC decisions, 29.0% (83 patients) based on the CRA’s decisions, and 12.9% (37 patients)
         based on the PI’s decisions.
         
      </p><div class="figs">
      <div class="table"><p><a onclick="popup('http://www.trialsjournal.com/content/16/1/15/table/T2','T2',800,470); return false;" href="http://www.trialsjournal.com/content/16/1/15/table/T2"><strong>Table 2.</strong></a> <strong>Results of pre-screening of patients eligible for the clinical trials GETUG 14, GETUG
            15, GETUG 16, and GETUG 17</strong></div></div>
      <p style="line-height:160%">A total of 22 patients were found eligible for screening in an RCT based on at least
         two pre-screening methods; most pre-selections were for the same RCTs. Only one discrepancy
         was observed between decisions made at the MDM and the CRA (GETUG 17 versus GETUG
         16, respectively), but the PI retained neither.
      </p>
      <p style="line-height:160%">Discrepancies mainly concerned patients initially excluded during the MDC meetings
         (59 patients were proposed by the CRA and 14 were finally validated by the PI). Regarding
         patients initially proposed for an RCT during the MDC meetings, two patients were
         secondarily excluded by the CRA and, finally, the PI definitively excluded four patients.
         There was no patient who was not proposed by the CRA but was proposed either during
         an MDM or by the PI. Nevertheless, the PI proposed one patient who was not proposed
         either by the CRA or at the MDC meetings. Figure&nbsp;<a name="d73120e1214"></a><a onclick="popup('http://www.trialsjournal.com/content/16/1/15/figure/F3','',800,470); return false;" href="http://www.trialsjournal.com/content/16/1/15/figure/F3">3</a> summarizes these results in a Venn diagram.
         
      </p><div class="figs">
      <div class="fig"><p><a onclick="popup('http://www.trialsjournal.com/content/16/1/15/figure/F3','F3',800,470); return false;" href="http://www.trialsjournal.com/content/16/1/15/figure/F3"><img align="top" src="/content/figures/s13063-014-0535-7-3.gif" alt="thumbnail" class="thumbnail"><strong>Figure 3.</strong></a> <strong>Venn diagram of the pre-screening of patients eligible for four randomized clinical
            trials carried out at the Comprehensive Cancer Center in Rennes (GETUG 14, 15, 16,
            and 17).</strong> Pre-screening was based on the physicians’ decisions during the multidisciplinary
         cancer meetings (MDC team’s decisions), the decisions of the clinical research assistant
         (CRA’s decisions), and the principal investigator (PI’s decisions) after a systematic
         review of the MDC reports.
      </div></div>
      <p style="line-height:160%">The four MDC team’s pre-selections excluded by the PI were due to mistakes on the
         evaluation of some exclusion criteria during the MDMs (too high a PSA rate or the
         presence of a positive margin after surgery). Among the CRA's 47 pre-selections that
         were not retained by the PI, 35 were due to implicit information known only by the
         clinicians and not explicitly available in the MDC reports. For example, the PI excluded
         18 CRA proposals because the patients had a Gleason score of less than seven, but
         such a criterion was not described in the exclusion or inclusion criteria of the RCTs.
         In the same way, six patients could have been eligible for an RCT but the MDC teams
         judged another type of care more effective. Further, nine patients were excluded because
         they had some specific characteristics (vital status, combination of comorbidities,
         and wishes) not compatible with enrollment in the RCTs according to the MDC teams.
      </p>
   </div>
</section>
<section><a name="sec4"></a><h3>Discussion</h3>
   <div class="collapsible-content">
      <p style="line-height:160%">In this study, the pre-screening rate with MDC team’s decisions made during the MDMs
         was estimated to be at 9.1%. It is higher than rates previously reported in other
         studies (around 5% for oncology RCTs) <a name="d73120e1239"></a>[<a onclick="LoadInParent('#B4'); return false;" href="#B4">4</a>]. Nevertheless, the best pre-screening rate was estimated to be 12.9% (based on the
         PI’s decisions). This confirms that patient pre-screening in clinical cancer research
         could be improved by a systematic review of the MDC reports after MDMs.
      </p>
      <p style="line-height:160%">It has been shown that individual barriers, such as the time and effort required for
         patient recruitment for the physicians, are factors that decrease enrollment in RCTs
         <a name="d73120e1245"></a>[<a onclick="LoadInParent('#B6'); return false;" href="#B6">6</a>]. The present study found that all patients proposed by the PIs were also proposed
         by the CRA’s systematic review, except one. In other words, the CRA’s review resulted
         in the justified rejection of more than 200 of the 286 initial MDC reports. Thus,
         we argue that the addition of a manual (or a computerized) systematic review at the
         first step of the screening process (the pre-screening phase) could lead to substantial
         gains in time and effort for the physicians’ screening task afterwards.
      </p>
      <p style="line-height:160%">Nevertheless, the results showed that the pre-screening decision should not be based
         only on the information available in the MDC reports, since some data are missing
         (such as TNM staging), or are not explicit. These issues illustrate why the pre-screening
         rate (29.0%) is so high when the CRA makes the decision alone; because their decision
         relies only on the content of the MDC reports. Missing data cannot be used to exclude
         the patients who are then selected as being eligible for RCTs. From the perspective
         of automating this decision-making process using a recruitment support system, we
         can foresee that such a system will overestimate the number of patients potentially
         eligible for RCTs, just as the CRA has done.
      </p>
      <p style="line-height:160%">It is likely that the best approach for these systems is not intended to replace the
         physicians’ decision, but to help physicians by reminding them that every patient
         is potentially eligible for an available clinical trial. The main objective will therefore
         be more to avoid missing out on patients who could be included than deciding which
         patients should be included.
      </p>
      <p style="line-height:160%">Indeed, our result showed that clinical TNM staging and pathological TNM staging are
         missing in 68% and 76%, respectively, of the MDC reports proposed by pre-screening
         after correction by the PI (data not shown). From a decision-making perspective, missing
         and implicit data (only known by the physicians of the MDC teams) could be seen as
         problematic regarding patient selection, but our results showed that missing and implicit
         information usually led to the exclusion of patients. Thus, these results showed that
         missing and implicit data mainly caused an overestimation of patients eligible for
         RCTs, resulting in the decreased precision of the systematic (or automated) pre-screening,
         but this did not lead to the wrongful exclusion of eligible patients.
      </p>
      <p style="line-height:160%">It could be argued that observations in the present study reflect local patterns of
         pre-screening practice and medical record design. Indeed, centers with routine systematic
         pathology reporting, in line with international standards, could certainly have a
         better registration rate of clinical and pathological TNM staging and thus increase
         the performance, and above all precision, of systematic (or automated) pre-screening.
      </p>
      <p style="line-height:160%">This illustrates that the best pre-screening practices cannot be guaranteed without
         providing the essential information (such as TNM staging) at the time of pre-screening,
         but they are not limited due to the systematic (or automated) pre-screening methods
         themselves. The present study shows that despite the presence of numerous missing
         data concerning key elements for enrollment in RCTs in urologic oncology, the implementation
         of a manual (or a computerized) systematic review could optimize the pre-screening
         task by improving the pre-screening rate and by reducing the time and effort required
         for pre-screening by physicians.
      </p>
      <p style="line-height:160%">We did not succeed in discovering which factors could really impact the pre-screening
         rate, except for the number of MDC reports discussed per session. The low number of
         patients who are actually eligible in the present study could be a limit to the interpretation
         of such a result, but it confirmed at least that the workload during the MDC meetings
         is a major factor that decreases pre-screening performance and enrollment in RCTs
         in oncology. Therefore, this is a strong argument for research as investigated in
         the automatic selection of clinical trials based on eligibility criteria (ASTEC) project
         <a name="d73120e1261"></a>[<a onclick="LoadInParent('#B10'); return false;" href="#B10">10</a>], which aims to provide tools to physicians (oncologists) to make the recruitment
         of patients for RCTs easier and more automatic.
      </p>
   </div>
</section>
<section><a name="sec5"></a><h3>Conclusions</h3>
   <div class="collapsible-content">
      <p style="line-height:160%">The study found that a systematic review of medical reports could increase the cumulative
         pre-screening rates of four RCTs recruiting patients at the Comprehensive Cancer Center
         in Rennes from 9 to 13%. Also, we argue that such an additional systematic review
         during the first step of the screening process could lead to substantial gains in
         time and effort for physicians in their task of recruiting patients for RCTs.
      </p>
      <p style="line-height:160%">The study also showed that missing data in the MDC reports leads to a systematic review
         that over-includes non-eligible patients, but does not over-exclude eligible patients.
         Therefore, we confirm the potential gain in using the semi-automated selection of
         electronic MDC reports to avoid missing out on patients eligible for RCTs.
      </p>
      <p style="line-height:160%">To conclude, optimizing the pre-screening process represents an interesting way to
         improve patient enrollment in clinical trials, which remains particularly low in oncology
         research. The use of computerized pre-screening support systems to perform a systematic
         review of eligible patients could help to reach such an objective.
      </p>
   </div>
</section>
<section><a name="sec6"></a><h3>Abbreviations</h3>
   <div class="collapsible-content">
      <p style="line-height:160%">ASTEC: Automatic selection of clinical trials based on eligibility criteria</p>
      <p style="line-height:160%">CPP/CPPRB: French research ethics committee</p>
      <p style="line-height:160%">CRA: Clinical research assistant</p>
      <p style="line-height:160%">EHR: Electronic health records</p>
      <p style="line-height:160%">GETUG: French Genitourinary Tumor Group</p>
      <p style="line-height:160%">MDC: Multidisciplinary cancer</p>
      <p style="line-height:160%">MDM: Multidisciplinary cancer meeting</p>
      <p style="line-height:160%">PI: Principal investigator</p>
      <p style="line-height:160%">PSA: Prostate-specific antigen</p>
      <p style="line-height:160%">RCT: Randomized controlled trial</p>
      <p style="line-height:160%">TNM: Tumor, lymph node and metastasis classification of malignant tumors</p>
   </div>
</section>
<section><a name="sec7"></a><h3>Competing interests</h3>
   <div class="collapsible-content">
      <p style="line-height:160%">The authors declare that they have no competing interests.</p>
   </div>
</section>
<section><a name="sec8"></a><h3>Authors’ contributions</h3>
   <div class="collapsible-content">
      <p style="line-height:160%">MC is responsible for the ASTEC project coordination. MC and BCG conceptualized and
         designed the study. CB and OZ contributed in the data collection and pre-screening
         evaluation. BL, ELP, and RDC were responsible for the validation of patient pre-screening.
         BCG performed the statistical analysis. BCG and MC drafted the manuscript. All authors
         provided critical review and final approval.
      </p>
   </div>
</section>
<section><a name="ack"></a><h3>Acknowledgments</h3>
   <div class="collapsible-content">
      <p style="line-height:160%">The French National Research Agency under the TecSan program 2008 funded the ASTEC
         project (ASTEC number: ANR-08-003). The authors would like to especially thank Delphine
         Rosille, Sahar Bayat, Marc Carpentier, and Regis Duvauferrier for their valuable comments.
      </p>
   </div>
</section>
<section><a name="refs"></a><h3>References</h3>
   <div id="article-references" class="collapsible-content">
      <ol id="references">
         <li id="B1">
            <p><a name="B1"></a> Caldwell PHY,  Hamilton S,  Tan A,  Craig JC: <strong> Strategies for increasing recruitment to randomised controlled trials: systematic
                  review. </strong><p><em>PLoS Med</em> 2010,  <strong>7</strong><strong>:</strong>e1000368.  <a target="_blank" href="/pubmed/21085696">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=21085696">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0535-7&amp;bibl=B1" onclick="popup('/sfx_links?ui=s13063-014-0535-7&amp;bibl=B1','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B2">
            <p><a name="B2"></a> Bleyer A,  Montello M,  Budd T,  Saxman S: <strong> National survival trends of young adults with sarcoma: lack of progress is associated
                  with lack of clinical trial participation. </strong><p><em>Cancer</em> 2005,  <strong>103</strong><strong>:</strong>1891-1897.  <a target="_blank" href="/pubmed/15795902">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=15795902">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0535-7&amp;bibl=B2" onclick="popup('/sfx_links?ui=s13063-014-0535-7&amp;bibl=B2','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B3">
            <p><a name="B3"></a> Chow CJ,  Habermann EB,  Abraham A,  Zhu Y,  Vickers SM,  Rothenberger DA,  Al-Refaie WB: <strong> Does enrollment in cancer trials improve survival? </strong><p><em>J Am Coll Surg</em> 2013,  <strong>216</strong><strong>:</strong>774-780. 
               <p>discussion 780–781</p> <a target="_blank" href="/pubmed/23415510">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=23415510">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0535-7&amp;bibl=B3" onclick="popup('/sfx_links?ui=s13063-014-0535-7&amp;bibl=B3','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B4">
            <p><a name="B4"></a> Murthy VH: <strong> Participation in cancer clinical trials: race-, sex-, and age-based disparities. </strong><p><em>JAMA</em> 2004,  <strong>291</strong><strong>:</strong>2720-2726.  <a target="_blank" href="/pubmed/15187053">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=15187053">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0535-7&amp;bibl=B4" onclick="popup('/sfx_links?ui=s13063-014-0535-7&amp;bibl=B4','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B5">
            <p><a name="B5"></a> Lassale C,  Sibenaler C,  Behier J-M,  Pletan Y,  Courcier S: <strong> France, an attractive country for international clinical research: 2010 survey assessed
                  by Leem (French association of pharmaceutical companies). </strong><p><em>Therapie</em> 2011,  <strong>66</strong><strong>:</strong>1-15.  <a target="_blank" href="/pubmed/21466772">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=21466772">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0535-7&amp;bibl=B5" onclick="popup('/sfx_links?ui=s13063-014-0535-7&amp;bibl=B5','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B6">
            <p><a name="B6"></a> Grand MM,  O’Brien PC: <strong> Obstacles to participation in randomised cancer clinical trials: a systematic review
                  of the literature. </strong><p><em>J Med Imaging Radiat Oncol</em> 2012,  <strong>56</strong><strong>:</strong>31-39.  <a target="_blank" href="/pubmed/22339743">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=22339743">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0535-7&amp;bibl=B6" onclick="popup('/sfx_links?ui=s13063-014-0535-7&amp;bibl=B6','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B7">
            <p><a name="B7"></a> Mills EJ,  Seely D,  Rachlis B,  Griffith L,  Wu P,  Wilson K,  Ellis P,  Wright JR: <strong> Barriers to participation in clinical trials of cancer: a meta-analysis and systematic
                  review of patient-reported factors. </strong><p><em>Lancet Oncol</em> 2006,  <strong>7</strong><strong>:</strong>141-148.  <a target="_blank" href="/pubmed/16455478">PubMed&nbsp;Abstract</a> | <a target="_blank" href="http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&amp;cmd=prlinks&amp;retmode=ref&amp;id=16455478">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0535-7&amp;bibl=B7" onclick="popup('/sfx_links?ui=s13063-014-0535-7&amp;bibl=B7','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B8">
            <p><a name="B8"></a> Neuzillet Y,  Négrier S,  Fizazi K,  Pignot G,  Benchikh El Fegoun A,  Guillotreau J,  Culine S: <strong> The French clinical trials ongoing (GETUG and AFU) on urothelial carcinomas, kidney
                  and prostate cancers. </strong><p><em>Prog En Urol J Assoc Fr Urol Société Fr Urol</em> 2010,  <strong>20</strong>(Suppl 1)<strong>:</strong>S84-S89.   <a target="_blank" href="http://dx.doi.org/10.1016/S1166-7087(10)70035-X">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0535-7&amp;bibl=B8" onclick="popup('/sfx_links?ui=s13063-014-0535-7&amp;bibl=B8','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B9">
            <p><a name="B9"></a>R Core Team: 
               	<em>R: A language and environment for statistical computing</em>.  R Foundation for Statistical Computing, Vienna, Austria;  2014. <a href="/sfx_links?ui=s13063-014-0535-7&amp;bibl=B9" onclick="popup('/sfx_links?ui=s13063-014-0535-7&amp;bibl=B9','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
         <li id="B10">
            <p><a name="B10"></a> Besana P,  Cuggia M,  Zekri O,  Bourde A,  Burgun A: <strong> Using Semantic Web Technologies for Clinical Trial Recruitment. </strong>In <em>Semantic Web-Iswc 2010, Pt Ii</em>.  Edited by PatelSchneider PF, Pan Y, Hitzler P, Mika P, Zhang L, Pan JZ, Horrocks I, Glimm B.  Springer-Verlag Berlin, Berlin;  2010:34-49.   <a target="_blank" href="http://dx.doi.org/10.1007/978-3-642-17749-1_3">Publisher&nbsp;Full&nbsp;Text</a> <a href="/sfx_links?ui=s13063-014-0535-7&amp;bibl=B10" onclick="popup('/sfx_links?ui=s13063-014-0535-7&amp;bibl=B10','SFXMenu','460','420'); return false;"><img src="/sfx_links?getImage" alt="OpenURL" align="absmiddle"></a></p>
               <p class="totext"><script type="text/javascript">totext()</script></p>
            </p>
         </li>
      </ol>
   </div>
</section>
    <br class="clearall">
<div class="article-alert-signup-div">

<a class="close png_bg" id="closeHelpBox" >close</a>	
<div class="article-alert-signup rounded" > 
<span class="blurb left">Sign up to receive new article alerts from <em>Trials</em></span>

	
				<button name="articleAlertPreference.status" type="button" class="w74 right" onClick="window.location='/my/preferences'">Sign up</button>
	
</div>
</div></div>
    </div></div>
</div>


		</div>
</div>

    <hr class="hide" />
	
    

						
   
  
      
  
                  
  
                  
  
            
  
            
            


<div id="footer">

						
			<span class="views"><a id="mobile-view" href="?fmt_view=mobile">Mobile view</a> | <strong>Desktop view</strong></span>
			
	<div class="content">
    <div class="rounded ">
<div class="wrap-inner ">
        	
    <ul class="desktop">
                                                    
				        <li class="noborder"><a href="http://www.biomedcentral.com/about/tandc">Terms and Conditions</a></li>
<li><a href="http://www.biomedcentral.com/about/privacy">Privacy statement</a></li>
<li><a href="http://www.biomedcentral.com/presscenter">Press</a></li>
	<li><a href="http://www.biomedcentral.com/advertisers">Information for advertisers</a></li>
<li><a href="http://www.biomedcentral.com/about/bmcjobs">Jobs at BMC</a></li>
<li><a href="/support">Support</a></li>
<li><a href="/about/contact">Contact us</a></li>


    
    	    </ul>
    <p id="copyright">&copy; 2015 
	BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business&nbsp;Media.</p>
        </div>
</div>

	</div>

</div>
<div class="springer">
    <a href="http://www.springer.com/" target="blank"><img style="float:right; margin:0;" src="
    //www.biomedcentral.com/images/Springer_Branding_footer_logo.png" /></a>
</div>


<script>window.bmcIsMobile = "classic";</script>					    

<script>
// getElementsByClassName Polyfill
var getElementsByClassName=function(e,t,n){if(document.getElementsByClassName){getElementsByClassName=function(e,t,n){n=n||document;var r=n.getElementsByClassName(e),i=t?new RegExp("\\b"+t+"\\b","i"):null,s=[],o;for(var u=0,a=r.length;u<a;u+=1){o=r[u];if(!i||i.test(o.nodeName)){s.push(o)}}return s}}else if(document.evaluate){getElementsByClassName=function(e,t,n){t=t||"*";n=n||document;var r=e.split(" "),i="",s="http://www.w3.org/1999/xhtml",o=document.documentElement.namespaceURI===s?s:null,u=[],a,f;for(var l=0,c=r.length;l<c;l+=1){i+="[contains(concat(' ', @class, ' '), ' "+r[l]+" ')]"}try{a=document.evaluate(".//"+t+i,n,o,0,null)}catch(h){a=document.evaluate(".//"+t+i,n,null,0,null)}while(f=a.iterateNext()){u.push(f)}return u}}else{getElementsByClassName=function(e,t,n){t=t||"*";n=n||document;var r=e.split(" "),i=[],s=t==="*"&&n.all?n.all:n.getElementsByTagName(t),o,u=[],a;for(var f=0,l=r.length;f<l;f+=1){i.push(new RegExp("(^|\\s)"+r[f]+"(\\s|$)"))}for(var c=0,h=s.length;c<h;c+=1){o=s[c];a=false;for(var p=0,d=i.length;p<d;p+=1){a=i[p].test(o.className);if(!a){break}}if(a){u.push(o)}}return u}}return getElementsByClassName(e,t,n)}
</script>

						



<script type="text/javascript">
if (typeof jQuery == 'undefined') { document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/jquery.min.js' type='text/javascript'%3E%3C/script%3E")); }


document.documentElement.id = "js";

var site = {
			abbreviation: "",
	        type: "BMC_NICHE",
        portalId: "9001",
                section: "browse",
                page: "fulltext",
    		
									homePortal: "biomedcentral.com",
		
			siteShowAds: "true",
				showAds: "true",
				url: "trialsjournal.com",
			portal: false,
	        adpage_url: "trialsjournal.com/article/10.1186/s13063/014/0535/7",
        id: "10096",
	name: "Trials",
	plugins: {
		scrollable: (getElementsByClassName("scrollable").length > 0),
				flowplayer: ((document.getElementById("flowplayer") != null) || (getElementsByClassName("myPlayer").length > 0) || (document.getElementById("videoarticle") != null) || (getElementsByClassName("flowplayer").length > 0) || (document.getElementById("audio") != null) || (document.getElementById("elifeplayer") != null)),
		lightbox: ((document.getElementById("image-highlight") != null) || (getElementsByClassName("lightbox").length > 0)),
		thickbox: (getElementsByClassName("thickbox").length > 0),
		altmetric: ((document.getElementById("altmetric") != null) || (getElementsByClassName("altmetric").length > 0))
	}
	
};



if(typeof quoteSearchUri == "undefined") { quoteSearchUri=null; }
</script>



        <script type="text/javascript" src="http://www.bmcimg.com/javascript/journals/behaviours-0.js"></script>






		<script>
	if (site.plugins.scrollable == true) { 
		document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/jquery.scrollable-1.0.1.min.js' %3E%3C/script%3E")); 
		document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/jquery.tools.min.js'%3E%3C/script%3E"));
	}

	if (site.plugins.flowplayer == true) { 
		document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/flowplayer-3.2.6.min.js'%3E%3C/script%3E"));
	}

	if (site.plugins.lightbox == true) { 
		document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/browse_imagehighlight.js'%3E%3C/script%3E"));
		document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/jquery.colorbox.js' %3E%3C/script%3E"));
	}

	if (site.plugins.thickbox == true) { 
		document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/thickbox-compressed.js' %3E%3C/script%3E"));
		document.write(decodeURIComponent("%3Cscript src='/javascript/plugins/thickbox-flashhidden-patch.js' %3E%3C/script%3E"));
	}
	</script>





            <script type="text/javascript" src="http://www.bmcimg.com/javascript/plugins/jquery.fancybox-1.3.1.pack-0.js"></script>
            <script type="text/javascript" src="http://www.bmcimg.com/javascript/plugins/jquery.debug-0.js"></script>
                      <script type="text/javascript" src="http://www.bmcimg.com/javascript/email_preferences/email_preferences-0.js"></script>
                <script type="text/javascript" src="http://www.bmcimg.com/javascript/articles/articles-0.js"></script>
		<div id="fb-root"></div>











        <script type="text/javascript" src="/javascript/plugins/jquery.tagcloud.min-0.js"></script>




<!--[if lte IE 6]>
            <script type="text/javascript" src="/javascript/plugins/DD_belatedPNG_0.0.8a-0.js"></script>
    <script type="text/javascript">
        DD_belatedPNG.fix('.png_bg, ul.primary-nav li a, ul.primary-nav li a span, ul.secondary-nav li a, ul.secondary-nav li a span, ul li i, .plus-button, .facebook, .twitter, .fancy-bg, #fancybox-close');
    </script>
	                <link rel="stylesheet" type="text/css" href="http://www.bmcimg.com/css/hacks/ie6-0.css"/>
    <![endif]-->

<!-- Claudia Whitcombe wanted this comment here -->

       <div class="hide">
      <dl class="google-ad" id="x96banner">
        <dt style="display: block;" class="hide">
          <a class="skyscraper-ad" href="http://www.biomedcentral.com/advertisers/digital_advertising">Advertisement</a>
       </dt>
        <dd>
          <!-- OAS AD 'x96' begin -->
          <script type="text/javascript">
            OAS_AD('x96');
          </script>
        </dd>
      </dl>
    </div>  
    
</body>
</html>

